GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

CARLSBAD, Calif.--()--GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the Canaccord Genuity Medical Technologies & Diagnostics Form to be held in New York, NY at the Westin Grand Central Hotel on Thursday, November 17, 2016 at 1:30 p.m. Eastern Time. The presentation will be made available at http://ir.genmarkdx.com.

ABOUT GENMARK DIAGNOSTICS

GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark’s eSensor XT-8® system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor detection technology is also incorporated into GenMark’s sample-to-answer system, ePlex®. For more information, visit www.genmarkdx.com.

Contacts

GenMark Diagnostics, Inc.
Hany Massarany, 760-448-4325
President, Chief Executive Officer

Contacts

GenMark Diagnostics, Inc.
Hany Massarany, 760-448-4325
President, Chief Executive Officer